Cargando…

Clinical characteristics and mortality predictors of patients with cancer hospitalized by COVID-19 in a pediatric third-level referral center

BACKGROUND: More than 135 million COVID-19 cases (coronavirus disease 2019) have been reported worldwide until today, with over 2.9 million deaths. Several studies have demonstrated that disease severity is lower in the pediatric population than in adults; however, differences are described in patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernández-Regino, Laura-Monserrat, De Jesús Castillejos-López, Manuel, Aquino-Gálvez, Arnoldo, Velasco-Hidalgo, Liliana, García-Guzmán, Alda, Aguilar-Ortiz, Marco, Cárdenas-Cardos, Rocío, Torres-Espíndola, Luz María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366048/
https://www.ncbi.nlm.nih.gov/pubmed/35967576
http://dx.doi.org/10.3389/fped.2022.960334
_version_ 1784765471321489408
author Hernández-Regino, Laura-Monserrat
De Jesús Castillejos-López, Manuel
Aquino-Gálvez, Arnoldo
Velasco-Hidalgo, Liliana
García-Guzmán, Alda
Aguilar-Ortiz, Marco
Cárdenas-Cardos, Rocío
Torres-Espíndola, Luz María
author_facet Hernández-Regino, Laura-Monserrat
De Jesús Castillejos-López, Manuel
Aquino-Gálvez, Arnoldo
Velasco-Hidalgo, Liliana
García-Guzmán, Alda
Aguilar-Ortiz, Marco
Cárdenas-Cardos, Rocío
Torres-Espíndola, Luz María
author_sort Hernández-Regino, Laura-Monserrat
collection PubMed
description BACKGROUND: More than 135 million COVID-19 cases (coronavirus disease 2019) have been reported worldwide until today, with over 2.9 million deaths. Several studies have demonstrated that disease severity is lower in the pediatric population than in adults; however, differences are described in patients with chronic diseases, including oncological patients. Current world literature suggests patients with comorbidities, including cancer, have an increased risk of unfortunate outcomes. Therefore, our objective was to describe the clinical characteristics and epidemiological factors associated with mortality in a cohort of pediatric cancer patients hospitalized for COVID-19. METHODS: This is a retrospective, descriptive study of the cases of patients with cancer hospitalized for COVID-19. A total of 40 pediatrics were included in the analysis. Data from pediatric patients with COVID-19 included clinical and epidemiological records, laboratory, imaging studies, COVID-19 diagnostic methods, and medical treatment. RESULTS: Of the 40 pediatric patients admitted with cancer with a confirmed diagnosis of COVID-19, 42.5% were solid tumors, 40% leukemias, and 17.5% lymphomas. The clinical parameters associated with mortality were stage IV tumor (p = 0.029) and intubation (p < 0.001). The biochemical factors associated with lower survival were thrombocytopenia under 25,000 cells/mm(3) (p < 0.001), D-dimer over 1 μg/ml (p = 0.003), clinical malnutrition (p = 0.023), and disseminated intravascular coagulation (p = 0.03). CONCLUSION: Our findings showed that the fever was the most frequent symptom, and the clinical parameters associated with mortality were stage IV tumor, intubation, saturation percentage, RDW, platelets, creatinine, ALT, D-dimer, ferritin, and FiO2 percentage. The thrombocytopenia, D-dimer, nutritional status, and disseminated intravascular coagulation were significantly associated with lower survival.
format Online
Article
Text
id pubmed-9366048
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93660482022-08-12 Clinical characteristics and mortality predictors of patients with cancer hospitalized by COVID-19 in a pediatric third-level referral center Hernández-Regino, Laura-Monserrat De Jesús Castillejos-López, Manuel Aquino-Gálvez, Arnoldo Velasco-Hidalgo, Liliana García-Guzmán, Alda Aguilar-Ortiz, Marco Cárdenas-Cardos, Rocío Torres-Espíndola, Luz María Front Pediatr Pediatrics BACKGROUND: More than 135 million COVID-19 cases (coronavirus disease 2019) have been reported worldwide until today, with over 2.9 million deaths. Several studies have demonstrated that disease severity is lower in the pediatric population than in adults; however, differences are described in patients with chronic diseases, including oncological patients. Current world literature suggests patients with comorbidities, including cancer, have an increased risk of unfortunate outcomes. Therefore, our objective was to describe the clinical characteristics and epidemiological factors associated with mortality in a cohort of pediatric cancer patients hospitalized for COVID-19. METHODS: This is a retrospective, descriptive study of the cases of patients with cancer hospitalized for COVID-19. A total of 40 pediatrics were included in the analysis. Data from pediatric patients with COVID-19 included clinical and epidemiological records, laboratory, imaging studies, COVID-19 diagnostic methods, and medical treatment. RESULTS: Of the 40 pediatric patients admitted with cancer with a confirmed diagnosis of COVID-19, 42.5% were solid tumors, 40% leukemias, and 17.5% lymphomas. The clinical parameters associated with mortality were stage IV tumor (p = 0.029) and intubation (p < 0.001). The biochemical factors associated with lower survival were thrombocytopenia under 25,000 cells/mm(3) (p < 0.001), D-dimer over 1 μg/ml (p = 0.003), clinical malnutrition (p = 0.023), and disseminated intravascular coagulation (p = 0.03). CONCLUSION: Our findings showed that the fever was the most frequent symptom, and the clinical parameters associated with mortality were stage IV tumor, intubation, saturation percentage, RDW, platelets, creatinine, ALT, D-dimer, ferritin, and FiO2 percentage. The thrombocytopenia, D-dimer, nutritional status, and disseminated intravascular coagulation were significantly associated with lower survival. Frontiers Media S.A. 2022-07-28 /pmc/articles/PMC9366048/ /pubmed/35967576 http://dx.doi.org/10.3389/fped.2022.960334 Text en Copyright © 2022 Hernández-Regino, De Jesús Castillejos-López, Aquino-Gálvez, Velasco-Hidalgo, García-Guzmán, Aguilar-Ortiz, Cárdenas-Cardos and Torres-Espíndola. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pediatrics
Hernández-Regino, Laura-Monserrat
De Jesús Castillejos-López, Manuel
Aquino-Gálvez, Arnoldo
Velasco-Hidalgo, Liliana
García-Guzmán, Alda
Aguilar-Ortiz, Marco
Cárdenas-Cardos, Rocío
Torres-Espíndola, Luz María
Clinical characteristics and mortality predictors of patients with cancer hospitalized by COVID-19 in a pediatric third-level referral center
title Clinical characteristics and mortality predictors of patients with cancer hospitalized by COVID-19 in a pediatric third-level referral center
title_full Clinical characteristics and mortality predictors of patients with cancer hospitalized by COVID-19 in a pediatric third-level referral center
title_fullStr Clinical characteristics and mortality predictors of patients with cancer hospitalized by COVID-19 in a pediatric third-level referral center
title_full_unstemmed Clinical characteristics and mortality predictors of patients with cancer hospitalized by COVID-19 in a pediatric third-level referral center
title_short Clinical characteristics and mortality predictors of patients with cancer hospitalized by COVID-19 in a pediatric third-level referral center
title_sort clinical characteristics and mortality predictors of patients with cancer hospitalized by covid-19 in a pediatric third-level referral center
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366048/
https://www.ncbi.nlm.nih.gov/pubmed/35967576
http://dx.doi.org/10.3389/fped.2022.960334
work_keys_str_mv AT hernandezreginolauramonserrat clinicalcharacteristicsandmortalitypredictorsofpatientswithcancerhospitalizedbycovid19inapediatricthirdlevelreferralcenter
AT dejesuscastillejoslopezmanuel clinicalcharacteristicsandmortalitypredictorsofpatientswithcancerhospitalizedbycovid19inapediatricthirdlevelreferralcenter
AT aquinogalvezarnoldo clinicalcharacteristicsandmortalitypredictorsofpatientswithcancerhospitalizedbycovid19inapediatricthirdlevelreferralcenter
AT velascohidalgoliliana clinicalcharacteristicsandmortalitypredictorsofpatientswithcancerhospitalizedbycovid19inapediatricthirdlevelreferralcenter
AT garciaguzmanalda clinicalcharacteristicsandmortalitypredictorsofpatientswithcancerhospitalizedbycovid19inapediatricthirdlevelreferralcenter
AT aguilarortizmarco clinicalcharacteristicsandmortalitypredictorsofpatientswithcancerhospitalizedbycovid19inapediatricthirdlevelreferralcenter
AT cardenascardosrocio clinicalcharacteristicsandmortalitypredictorsofpatientswithcancerhospitalizedbycovid19inapediatricthirdlevelreferralcenter
AT torresespindolaluzmaria clinicalcharacteristicsandmortalitypredictorsofpatientswithcancerhospitalizedbycovid19inapediatricthirdlevelreferralcenter